The Biden administration announced tariffs on Chinese-made PPE, but some American manufacturers feel it's too little, too late. Despite the tariffs, China has become a dominant supplier. Previous efforts by the Trump administration to boost domestic PPE production were hindered due to financial issues under the Biden administration. The lack of action has allowed China to increase its market share in medical gloves to the U.S.
Key Points
Tariffs on Chinese-made PPE announced by the Biden administration
China has become a dominant supplier of medical gloves to the U.S.
Previous efforts to boost domestic PPE production were affected by financial issues under the Biden administration
Pros
Tariffs aim to support and sustain a strong domestic industrial base for essential medical supplies
Efforts by the Trump administration to boost domestic PPE production were initiated
Cons
Tariffs may not be sufficient to counter China's dominance in the market
Financial issues under the Biden administration hindered previous domestic PPE production efforts